These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 21846996)

  • 1. Identification by differential tissue proteome analysis of talin-1 as a novel molecular marker of progression of hepatocellular carcinoma.
    Kanamori H; Kawakami T; Effendi K; Yamazaki K; Mori T; Ebinuma H; Masugi Y; Du W; Nagasaka K; Ogiwara A; Kyono Y; Tanabe M; Saito H; Hibi T; Sakamoto M
    Oncology; 2011; 80(5-6):406-15. PubMed ID: 21846996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of human hepatocellular carcinoma-related biomarkers by two-dimensional difference gel electrophoresis and mass spectrometry.
    Lee IN; Chen CH; Sheu JC; Lee HS; Huang GT; Yu CY; Lu FJ; Chow LP
    J Proteome Res; 2005; 4(6):2062-9. PubMed ID: 16335951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glutamine synthetase as an early marker for hepatocellular carcinoma based on proteomic analysis of resected small hepatocellular carcinomas.
    Long J; Lang ZW; Wang HG; Wang TL; Wang BE; Liu SQ
    Hepatobiliary Pancreat Dis Int; 2010 Jun; 9(3):296-305. PubMed ID: 20525558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of macrophage migration inhibitory factor induces angiogenesis and deteriorates prognosis after radical resection for hepatocellular carcinoma.
    Hira E; Ono T; Dhar DK; El-Assal ON; Hishikawa Y; Yamanoi A; Nagasue N
    Cancer; 2005 Feb; 103(3):588-98. PubMed ID: 15612021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neural cadherin overexpression is a predictive marker for early postoperative recurrence in hepatocellular carcinoma patients.
    Seo DD; Lee HC; Kim HJ; Min HJ; Kim KM; Lim YS; Chung YH; Lee YS; Suh DJ; Yu E; Chun SY
    J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 1):1112-8. PubMed ID: 17944884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Importin-α1 as a novel prognostic target for hepatocellular carcinoma.
    Yoshitake K; Tanaka S; Mogushi K; Aihara A; Murakata A; Matsumura S; Mitsunori Y; Yasen M; Ban D; Noguchi N; Irie T; Kudo A; Nakamura N; Tanaka H; Arii S
    Ann Surg Oncol; 2011 Jul; 18(7):2093-103. PubMed ID: 21286940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomic profiling of hepatocellular carcinoma in Chinese cohort reveals heat-shock proteins (Hsp27, Hsp70, GRP78) up-regulation and their associated prognostic values.
    Luk JM; Lam CT; Siu AF; Lam BY; Ng IO; Hu MY; Che CM; Fan ST
    Proteomics; 2006 Feb; 6(3):1049-57. PubMed ID: 16400691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical analysis of tumor biological factors in hepatocellular carcinoma: relationship to clinicopathological factors and prognosis after hepatic resection.
    Nanashima A; Yano H; Yamaguchi H; Tanaka K; Shibasaki S; Sumida Y; Sawai T; Shindou H; Nakagoe T
    J Gastroenterol; 2004; 39(2):148-54. PubMed ID: 15069621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stathmin overexpression cooperates with p53 mutation and osteopontin overexpression, and is associated with tumour progression, early recurrence, and poor prognosis in hepatocellular carcinoma.
    Yuan RH; Jeng YM; Chen HL; Lai PL; Pan HW; Hsieh FJ; Lin CY; Lee PH; Hsu HC
    J Pathol; 2006 Aug; 209(4):549-58. PubMed ID: 16739096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased expression of liver-type fatty acid-binding protein is associated with poor prognosis in hepatocellular carcinoma.
    Wang B; Tao X; Huang CZ; Liu JF; Ye YB; Huang AM
    Hepatogastroenterology; 2014; 61(133):1321-6. PubMed ID: 25436304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of osteopontin is associated with intrahepatic metastasis, early recurrence, and poorer prognosis of surgically resected hepatocellular carcinoma.
    Pan HW; Ou YH; Peng SY; Liu SH; Lai PL; Lee PH; Sheu JC; Chen CL; Hsu HC
    Cancer; 2003 Jul; 98(1):119-27. PubMed ID: 12833464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative proteomics reveal up-regulated protein expression of the SET complex associated with hepatocellular carcinoma.
    Li C; Ruan HQ; Liu YS; Xu MJ; Dai J; Sheng QH; Tan YX; Yao ZZ; Wang HY; Wu JR; Zeng R
    J Proteome Res; 2012 Feb; 11(2):871-85. PubMed ID: 22082227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hcc-2, a novel mammalian ER thioredoxin that is differentially expressed in hepatocellular carcinoma.
    Nissom PM; Lo SL; Lo JC; Ong PF; Lim JW; Ou K; Liang RC; Seow TK; Chung MC
    FEBS Lett; 2006 Apr; 580(9):2216-26. PubMed ID: 16574106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proline-directed protein kinase FA is a powerful and independent prognostic predictor for progression and patient survival of hepatocellular carcinoma.
    Hsu YC; Fu HH; Jeng YM; Lee PH; Yang SD
    J Clin Oncol; 2006 Aug; 24(23):3780-8. PubMed ID: 16754939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of metastasis-associated protein 2 is associated with hepatocellular carcinoma size and differentiation.
    Lee H; Ryu SH; Hong SS; Seo DD; Min HJ; Jang MK; Kwon HJ; Yu E; Chung YH; Kim KW
    J Gastroenterol Hepatol; 2009 Aug; 24(8):1445-50. PubMed ID: 19702911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of novel aberrant methylation of BASP1 and SRD5A2 for early diagnosis of hepatocellular carcinoma by genome-wide search.
    Moribe T; Iizuka N; Miura T; Stark M; Tamatsukuri S; Ishitsuka H; Hamamoto Y; Sakamoto K; Tamesa T; Oka M
    Int J Oncol; 2008 Nov; 33(5):949-58. PubMed ID: 18949357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Proteomic analysis on metastasis-associated proteins of hepatocellular carcinoma tissues].
    Song HY; Liu YK; Cui JF; Zhang LJ; Dai Z; Feng JT; Feng JX; Shen HL; Yang PY
    Zhonghua Gan Zang Bing Za Zhi; 2005 May; 13(5):331-4. PubMed ID: 15918964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased expression of Wiskott-Aldrich syndrome protein family verprolin-homologous protein 2 correlated with poor prognosis of hepatocellular carcinoma.
    Yang LY; Tao YM; Ou DP; Wang W; Chang ZG; Wu F
    Clin Cancer Res; 2006 Oct; 12(19):5673-9. PubMed ID: 17020969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection and identification of peroxiredoxin 3 as a biomarker in hepatocellular carcinoma by a proteomic approach.
    Qiao B; Wang J; Xie J; Niu Y; Ye S; Wan Q; Ye Q
    Int J Mol Med; 2012 May; 29(5):832-40. PubMed ID: 22344546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteomic analysis and molecular characterization of tissue ferritin light chain in hepatocellular carcinoma.
    Park KS; Kim H; Kim NG; Cho SY; Choi KH; Seong JK; Paik YK
    Hepatology; 2002 Jun; 35(6):1459-66. PubMed ID: 12029631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.